Low-dose inhaled and nasal corticosteroid use and the risk of cataracts

European Respiratory Journal

Volumn 27, Issue 6, 2006, Pages 1168-1174

  Ernst, Pierre ^a,b   Baltzan, M ^a,c,d   Deschenes J ^a   Suissa, S ^a,c  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d and a member of the Respiratory Medicine Program Committee of the College of Family Physicians of Canada   (Canada)

Author keywords

Asthma; Cataracts; Chronic obstructive pulmonary disease; Elderly; Inhaled corticosteroids; Nasal corticosteroids

Indexed keywords

ALLOPURINOL; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; CORTISONE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; DIURETIC AGENT; FLUNISOLIDE; FLUTICASONE; GOLD SALT; HYDROCORTISONE; IPRATROPIUM BROMIDE; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; MIOTIC AGENT; NEDOCROMIL; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; THEOPHYLLINE; TRIAMCINOLONE;

AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EXPOSURE; FEMALE; HUMAN; LOW DRUG DOSE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CANADA; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; DOSE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; RISK;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATARACT; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUEBEC; RISK;

EID: 33750696639     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00043005     Document Type: Article

References (18)

1. Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev 1995; 17: 336-346.
2. Congdon NG. Prevention strategies for age related cataract: present limitations and future possibilities. Br J Ophthalmol 2001; 85: 516-520.
3. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337: 8-14.
4. Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998; 280: 539-543.
5. Jick SS, Vasilakis-Scaramozza C, Maier WC. The risk of cataract among users of inhaled steroids. Epidemiology 2001; 12: 229-234.
6. National Institutes of Health. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics - 2002. J Allergy Clin Immunol 2002; 110: Suppl. 5, S141-S219.
7. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Int Med 1999; 159: 941-955.
8. Todd G, Acerini C, Ross-Russell R, Zahra S, Warner J, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-461.
9. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48: 999-1009.
10. Haynes RC. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P, eds. The Pharmacological Basic of Therapeutics. New York, Pergamon Press, Inc., 1990; pp. 1431-1462.
11. National Heart, Lung, and Blood Institute, National Institutes of Health. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2. NIH Publication No. 97-4051. Bethesda, MD, National Heart, Lung, and Blood Institute, 1997.
12. Boulet L-P, Becker A, Bérubé D, Beveridge R, Ernst P. Summary of recommendations from the asthma consensus report, 1999. Can Med Assoc J 1999; 161: Suppl. 11, s1-s62.
13. Garbe E, Suissa S, LeLorier J. Exposure to allopurinol and the risk of cataract extraction in elderly patients. Arch Ophthalmol 1998; 116: 1652-1656.
14. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226-235.
15. 2-agonist therapy in asthma. Am J Respir Crit Care Med 2001; 164: 923-932.
16. Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 2003; 327:891-896.
17. The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343:1902-1909.
18. Bourbeau J, Ernst P, Cockcoft D, Suissa S. hihaled corticosteroids and hospitalisation due to exacerbation of COPD. Eur Respir J 2003; 22: 286-289.